Picture1

List of Protocol Approved periode 2023-2026 (Active File)

Name of PI

dr. Ralph Girson Gunarsa, Sp.PD-KHOM

Prof. Dr. Antonia Anna Lukito, MD, PhD, FIHA, FAPSIC, FAsCC, FSCAI

Dr. Cosmas Rinaldi A. Lesmana Ph.D., Sp.PD, KGEH, F.A.C.P, F.A.C.G, FINASIM

Dr.rer.nat Juandy Jo

dr. Ralph Girson Gunarsa, Sp.PD-KHOM

Dr.dr.Theo Audi Yanto,Sp.PD

Prof.dr. Herawati Sudoyo,PhD

Drg. Yoanne Imanuella, Sp.Pros

Dr. Soebagijo Adi Soelistijo, dr, SpPD, K-EMD, FINASIM, FACP

dr. Jephtah Furano Lumban Tobing, SpOT(K)

dr. Priscilla Muliantara

dr. Priscilla Muliantara

Prof. Dr.dr. Cucunawangsih, Sp.MK(K)

Adela Girly Dio Nensa

Apt.Dra. Effi Setiawati, MKM, M.Biomed

drg. Mirza Aryanto, Sp.KG

Dr.dr.Herlina Uinarni, Sp.Rad (K), Subsp. RA(K), PAK(K) 

dr.Ita Muharram Sari

dr. Kathleen J.G. Soenario, SpOG

Prof. dr. Herawati Sudoyo, PhD

dr. Danny Halim, Sp.BS, PhD

Caroline Riady

Dr.dr.Sunanto Ng,. Sp.JP

Title of Research

Marker Assisted Selective Therapy in Rare Cancers: Knowledge Database Establishing Registry

DynamX Bioadaptor Global Post-Market Registry: Clinical Trial of the Elixir Medical DynamX Coronary Bioadaptor System (Bio Restore)

Survey on Current Status and Treatment of Hepatitis and Liver Cancer in the Asia Pacific Region

Donor-derived Induced Pluripotent Stem Cells (iPSC) for the Discovery of Molecular Causes of Cardiometabolic Diseases

A Randomized, Double-Blind, Multicenter, Phase II/III Clinical Study of Serpulimab in Combination with Bevacizumab and Chemotherapy (XELOX) versus Placebo in Combination with Bevacizumab and Chemotherapy (XELOX) in First-Line Treatment of Patients with Metastatic Colorectal Cancer (mCRC)

Phase 3, Double Blind, Placebo Controlled Study of RECCE ® 327 Topical Gel for the Treatment of Diabetic Foot Ulcer Infections

The Effect of Using the Mandibular Advancement Device-Y Prototype on the Apnea Hypopnea Index, Heart Rate, Oxygen Saturation, and Sleep Quality in Patients with Obstructive Sleep Apnea

Reconstructing Human Migration History to Sahul: Genetics, Social Structure, and Cultural Learning Insights from O’Hongana Manyawa Hunter-Gatherers of Indonesia

A retrospective real-world study to investigate cardiovascular risk profile among newly diagnosed Type 2 diabetes mellitus patients in Southeast Asia (CRISTAL SEA)

Genetic–Nutritional Interactions in Adolescent Idiopathic Scoliosis: A Nutrigenomics Approach

Evaluation and Comparison of The In Vivo Efficacy of Three Cosmetic Products Using Chromametry in Healthy Asian Skin Type Female and Male Subjects

Evaluation Of The In Vivo Skin Irritation Potential Of Seventeen Cosmetic Products Using Single Patch Test In Healthy Asian Skin Type Male And Female Subjects

Clinical Prognosis and Molecular Epidemiology of Bacteremia Caused by Third-Generation Cephalosporin Resistant (3GCR) Escherichia coli and Klebsiella spp.: An International Multicenter Observational Study

THE EFFECT OF AUDIOVISUAL DISTRACTION TECHNIQUES ON THE INTENSITY OF PAIN IN CHEMOTHERAPY PATIENTS AT A RUMAH SINGGAH  IN TANGERANG

Bioequivalence Pilot Study of Gliclazide 60 mg Modified Release Caplet manufactured by PT Lapi Laboratories in Comparison with Gliclazide 60 mg Modified Release Tablet, Diamicron® MR manufactured by Les Laboratories Servier Industrie, France; Registered by PT Darya Varia Laboratoria Tbk, Indonesia; Imported and Marketed by PT Servier Indonesia under Fasting Condition

DEVELOPMENT OF CLINICAL DECISION SUPPORT SYSTEM MODELS FOR ASSESSING AND EVALUATING ENDODONTICALLY TREATED TEETH RESTORATIVE OUTCOMES 

Comparative study of the Sagittal and Coronal Curvature of the Spine of Indonesian Flag-bearer cadets (Paskibraka) with patients undergoing Whole Spine Radiography: a multicenter study 

Third Enhanced Control of Hypertension and Thrombectomy Stroke Study

Prospective Clinical Validation of Self-sampling Based HPV Genotyping Assay

Mapping the bio-cultural impact of Papuan migrations into Wallacea

Evaluating the Efficacy and Safety of Intraparenchymal Transplantation of Umbilical Cord Mesenchymal Stem Cell in Patients with Subacute Ischemic Stroke: A Prospective Interventional Study

Creating Value in a Differentiated Private Hospital Network: A Comparative Study of Acute Ischemic Stroke Care Across Hospital Models

Prospective, multicentre, two-cohorts single-arm clinical investigation evaluating Safety, Effectiveness and Performance of Angimis Atherectomy System for the treatment of Non-crossable and/or Non-dilatablE lesions in CorONary Arteries disease (NEON study)

Year

2023

2023

2023

2024

2024

2024

2024

2025

2025

2025

2026

2026

2026

2026

2026

2026

2026

2026

2026

2026

2026

2026

2026

No.Protocol

2310021-03

2311022-03

2312023-03

2401002-01

2405005-03

2408009-03

2412016-01

2511011-05

2511012-03

2512013-02

2601001-05

2601002-05

2602003-03

2602004-04

2602005-05

2602006-05

2603007-05

2603008-05

2604009-03

2605010-01

2605011-03

2606012-03

2607013-03

Period of Ethical Approval

20 January 2024 - 19 January 2025 extend to 19 Jan 2027

26 January 2024 - 25 January 2025 extend to 13 June 2027

12 January 2024 - 11 January 2025 extend to Jan 2026

20 March 2024 - 19 March 2025 extend to 7 July 2027

5 July 2024 - 4 July 2025 extend to 11 July 2026 , extend to 12 May 2027

8 November 2024 - 7 November 2025 extend to October 2026

14 January 2025 - 13 January 2026 extend 8 May 2027

12 February 2026 - 11 February 2027

18 February 2026 - 17 February 2027

14 February 2026 - 13 February 2027

'3 March 2026 - 2 March 2027

12 February 2026 - 11 February 2027

8 June 2026 - 7 June 2027

7 April 2026 - 6 April 2027

24 April 2026 - 23 April 2027

18 September 2026 - 17 September 2027

28 July 2026 - 27 July 2027

8 June 2026 - 7 June 2027

17 July 2026 - 16 July 2027

11 August 2026 - 10 August 2027

7 August 2026 - 6 August 2027

17 July 2026 - 16 July 2027

20 August 2026 - 19 August 2027